Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging.
Shuangshuang RenJie YangLan MaXincong LiWenlei WuChao LiuJian HeLeiying MiaoPublished in: ACS applied materials & interfaces (2018)
Designing a smart nanotheranostic system has recently attracted tremendous attention and is highly desirable for realizing targeted cancer therapy and early diagnosis. Herein we report the fabrication of smart nanotheranostic system using multiresponsive gatekeeping protocol of mesoporous silica nanoparticles (MSN). Acid, oxidative stress and redox sensitive manganese oxide (MnO x) coated superparamagnetic iron oxide nanoparticle (SPION) were employed as nanolids to regulate the camptothecin drug release from the channels of mesoporous silica and achieve responsive dual-mode MRI contrast. The nonvehicle showed high magnetization and T2 contrast in magnetic resonance imaging (MRI) due to the significant density of SPION onto the surface of MSN, and at the same time the MnO x shell degradation release Mn2+ which enhanced the T1MRI visualization. The efficacy of responsive drug delivery system was investigated on pancreatic cancer cells and tumor-bearing mice, and results reinforced that MnO x-SPION@MSN@CPT nonvehicle is efficacious against cancer cells. We envision that our unique and multiresponsive nanoplatform may find applications in effective delivering of imaging and therapeutic agents to wide range of diseases besides cancer.
Keyphrases
- contrast enhanced
- cancer therapy
- magnetic resonance imaging
- drug delivery
- iron oxide
- diffusion weighted
- magnetic resonance
- computed tomography
- diffusion weighted imaging
- oxidative stress
- high resolution
- randomized controlled trial
- drug release
- papillary thyroid
- fluorescence imaging
- working memory
- dna damage
- high fat diet induced
- type diabetes
- insulin resistance
- ischemia reperfusion injury
- drug induced
- young adults
- lymph node metastasis
- iron oxide nanoparticles
- adverse drug
- oxide nanoparticles
- heat shock protein